BioSpace News Archive

Business

Standigm Raises US $11.5 Million in Series B Round Funding to Advance its AI-powered Drug Pipelines toward License-out.

Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced it has raised $11.5 million in a Series B funding round led by Mirae Asset Venture Investment and Mirae Asset Capital.

March 29, 2019
·
2 min read
Policy

Wolf Popper LLP Announces That It Has Filed A Securities Class Action Lawsuit Against First Choice Healthcare Solutions and its Former CEO Christian Romandetti

Wolf Popper LLP announced that it has filed a securities class action lawsuit in the United States District Court for the Middle District of Florida against First Choice Healthcare Solutions, Inc. and its former Chairman, CEO, and President Christian Romandetti, Sr.

March 29, 2019
·
2 min read
FDA

FDA approves new oral treatment for multiple sclerosis

The U.S. Food and Drug Administration approved Mavenclad tablets to treat relapsing forms of multiple sclerosis in adults, to include relapsing-remitting disease and active secondary progressive disease.

March 29, 2019
·
4 min read
Deals

Hometown Heart Terminates Relationship With Eaze

DionyMed Brands Inc., a multi-state cannabis brands platform, announces that Hometown Heart, a licensed California delivery service managed by DionyMed, has terminated its relationship with customer acquisition provider Eaze Technologies, Inc., formerly Eaze Solutions, Inc..

March 29, 2019
·
3 min read
Aqualitas Receives Sales Licence under Health Canada’s Cannabis Act

Aqualitas Inc. (Aqualitas), a licensed producer of certified organically grown cannabis, is pleased to announce that it has been awarded a sales licence by Health Canada.

March 29, 2019
·
1 min read